BridgeMD
New treatment option for Mycoplasma Genitalium
Official title "Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)"
ClinicalTrials.gov ID: NCT07088419
What this study is testing
What is Tinidazole?
Tinidazole is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for mycoplasma genitalium.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The objective is to estimate the efficacy of tinidazole for the treatment of Mycoplasma genitalium (MG) among male patients who have been diagnosed with non-gonococcal urethritis (NGU) at the Public Health - Seattle \&King County (PHSKC) Sexual Health Clinic (SHC). Tinidazole was approved by the Food and Drug Administration (FDA) in May 2004 to treat other infections (i.e., trichomoniasis, giardiasis, amebiasis, bacterial vaginosis) but has not been systematically tested for effectiveness against M.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- ≥18 years of age
- Clinical diagnosis of NGU
- Urogenital MG documented by a positive NAAT in the prior 7 days
- Fluent in English
- Assigned male at birth
You likely can't join if
- Known allergy to tinidazole
- Other contraindications to tinidazole
- At the clinician's discretion
See the full eligibility criteria
- ≥18 years of age
- Clinical diagnosis of NGU
- Urogenital MG documented by a positive NAAT in the prior 7 days
- Fluent in English
- Assigned male at birth
- Attending the PHSKC SHC
- Able to provide informed consent
- Able to undergo a test of cure (TOC) 21 days after completing the tinidazole regimen
- Known allergy to tinidazole
- Other contraindications to tinidazole
- At the clinician's discretion
The study team makes the final eligibility decision.
Where it's taking place
- Seattle, Washington, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seattle, Washington, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.